NINDS Neuroscience Funding Announcements

Exploratory/Developmental Projects in Translational Research for Neuromuscular Disease (R21)

Funding Contact(s): John Porter, Ph.D.
Funding Categories: Neurogenetics

Brief Description:
This Funding Opportunity Announcement (FOA), from the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), requests applications for projects intended to complete preliminary steps in the pipeline for the preclinical development of therapeutics for neuromuscular diseases. Such projects, if successful, should lead directly to a subsequent project that will include all remaining activities for submission of an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application to the Food and Drug Administration (FDA). Only Aims required for therapy development can be supported in this program. This program excludes clinical research, basic research, and studies of disease mechanisms.

Grant Mechanism: R21
NIH Guide: PAR-08-228
Release Date: 2008-08-05
Expiration Date: 2011-09-08